Metraipolis › archive › dc_ce2281d68ca9

Baseline PSMA tumor volume as a prognostic marker in radical radiotherapy for prostate cancer: a propensity score-weighted retrospective analysis — Europe PMC PMID:41071425

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41071425
DOI
10.1007/s12149-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-09T10:50:44.021Z
SHA-256 of the archived text
6f9e34dc5458eb3dfbefd2b49ba6d912324de81cd719f5c4cd1411431b058a5d
Stable URL of this page
https://metraipolis.com/documento/dc_ce2281d68ca9

How to cite

Baseline PSMA tumor volume as a prognostic marker in radical radiotherapy for prostate cancer: a propensity score-weighted retrospective analysis — Europe PMC PMID:41071425 — Europe PMC (en), https://europepmc.org/article/MED/41071425 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ce2281d68ca9 (Metraipolis archive dc_ce2281d68ca9, sha256 6f9e34dc5458eb3dfbefd2b49ba6d912324de81cd719f5c4cd1411431b058a5d)
BibTeX
@misc{dcce2281d68ca9,
  title = {Baseline PSMA tumor volume as a prognostic marker in radical radiotherapy for prostate cancer: a propensity score-weighted retrospective analysis — Europe PMC PMID:41071425},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41071425},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ce2281d68ca9; sha256 6f9e34dc5458eb3dfbefd2b49ba6d912324de81cd719f5c4cd1411431b058a5d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41071425. Agents can read the archived copy with the MCP tool read_document.